• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Prosensa Holding NV

+ Add to Watchlist


9.4300 USD 0.2300 2.38%

As of 20:10:00 ET on 07/10/2014.

Snapshot for Prosensa Holding NV (RNA)

Open: 9.4600 Day's Range: 9.0300 - 9.6800 Volume: 270,349
Previous Close: 9.6600 52wk Range: 3.4310 - 34.5500 1-Yr Rtn: -

Stock Chart for RNA

No chart data available.
  • RNA:US 9.4330
  • 1D
  • 1M
  • 1Y
Interactive RNA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RNA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -0.6370
Est. PEG Ratio -
Market Cap (M USD) 330.07
Shares Outstanding (M) 35.00
30 Day Average Volume 486,005
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RNA

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for RNA

Prosensa Holding NV is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The Company's primary focus is on neuromuscular and neurodegenerative disorders, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease.

Hans G C P SchikanCEO/Member-Mgmt BoardBerndt A E ModigCFO/Member-Mgmt Board
Willem W Van WeperenChief Commercial OfficerGiles CampionSenior VP:Research & Dev
More Company Profile & Key Executives for RNA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil